Oral molecular glue degrader with or without spartalizumab shows immune activation and tumour control in solid tumours

ctDNA positivity predicts poor response and recurrence risk in triple-negative breast cancer

ZL-1310 shows promising activity in DLL3-positive neuroendocrine carcinomas

ctDNA predicts early treatment response in HPV-associated anal cancer

The potential of T-cell engagers in SCLC treatment

Distinct lung microbiome patterns identified in Portuguese patients with lung cancer

Challenges in high-risk NMIBC: Addressing current unmet needs to optimise patient care

EAU 2026: Updates in NMIBC

Pembrolizumab alone achieves bladder preservation and ctDNA predicts outcomes in muscle-invasive bladder cancer

Induction ipilimumab plus nivolumab followed by chemoradiotherapy achieves high bladder preservation and survival in MIBC

Neoadjuvant cabozantinib plus nivolumab before cytoreductive nephrectomy shows promising responses in metastatic clear cell RCC

ASCO GU 2026: Updates in bladder cancer